These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3476860)

  • 1. A rating scale for Gilles de la Tourette's syndrome: description, reliability, and validity data.
    Goetz CG; Tanner CM; Wilson RS; Shannon KM
    Neurology; 1987 Sep; 37(9):1542-4. PubMed ID: 3476860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonidine treatment of Gilles de la Tourette's syndrome.
    Leckman JF; Hardin MT; Riddle MA; Stevenson J; Ort SI; Cohen DJ
    Arch Gen Psychiatry; 1991 Apr; 48(4):324-8. PubMed ID: 2009034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome.
    Pappert EJ; Goetz CG; Louis ED; Blasucci L; Leurgans S
    Neurology; 2003 Oct; 61(7):936-40. PubMed ID: 14557563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods.
    Goetz CG; Tanner CM; Wilson RS; Carroll VS; Como PG; Shannon KM
    Ann Neurol; 1987 Mar; 21(3):307-10. PubMed ID: 3300518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
    Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
    Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics.
    Shapiro AK; Shapiro E; Eisenkraft GJ
    Arch Gen Psychiatry; 1983 Nov; 40(11):1235-40. PubMed ID: 6139100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep brain stimulation of anteromedial globus pallidus interna for severe Tourette's syndrome.
    Cannon E; Silburn P; Coyne T; O'Maley K; Crawford JD; Sachdev PS
    Am J Psychiatry; 2012 Aug; 169(8):860-6. PubMed ID: 22772329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
    Singer HS; Brown J; Quaskey S; Rosenberg LA; Mellits ED; Denckla MB
    Pediatrics; 1995 Jan; 95(1):74-81. PubMed ID: 7770313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual feedback of own tics increases tic frequency in patients with Tourette's syndrome.
    Brandt VC; Lynn MT; Obst M; Brass M; Münchau A
    Cogn Neurosci; 2015; 6(1):1-7. PubMed ID: 25185800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tics: from Itard to the neuroleptics].
    Dugas M
    Rev Neurol (Paris); 1986; 142(11):817-23. PubMed ID: 3547547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eye signs and tic disorders: Gilles de la Tourette's syndrome.
    Goetz CG
    J Am Optom Assoc; 1997 Nov; 68(11):688-92. PubMed ID: 9409103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Freud and the diagnosis of Gilles de la Tourette's illness.
    Kushner HI
    Hist Psychiatry; 1998 Mar; 9(33):1-25. PubMed ID: 11620004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial.
    Goetz CG; Stebbins GT; Thelen JA
    Mov Disord; 1994 May; 9(3):315-7. PubMed ID: 7913738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine in Gilles de la Tourette's syndrome.
    Roos RA; Minderaa RB; Cohen AP; Van de Wetering BJ; Van Woerkom TC
    Ann Neurol; 1987 Dec; 22(6):773-4. PubMed ID: 3324950
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of Yi-Gan-san on the psychiatric behavior of children and adolescents with Tourette's Syndrome: A randomized, double-blind, controlled preliminary study.
    Huang CH; Liao WL; Lee DY; Chou IC; Wang MY; Hsieh CL
    J Ethnopharmacol; 2022 May; 290():115098. PubMed ID: 35182665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term treatment of Tourette's syndrome with clonidine: a clinical perspective.
    Leckman JF; Detlor J; Harcherik DF; Ort S; Shaywitz BA; Cohen DJ
    Neurology; 1985 Mar; 35(3):343-51. PubMed ID: 3883235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are premonitory urges a prerequisite of tic inhibition in Gilles de la Tourette syndrome?
    Ganos C; Kahl U; Schunke O; Kühn S; Haggard P; Gerloff C; Roessner V; Thomalla G; Münchau A
    J Neurol Neurosurg Psychiatry; 2012 Oct; 83(10):975-8. PubMed ID: 22842713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult tics in Gilles de la Tourette's syndrome: description and risk factors.
    Goetz CG; Tanner CM; Stebbins GT; Leipzig G; Carr WC
    Neurology; 1992 Apr; 42(4):784-8. PubMed ID: 1565232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
    Cui YH; Zheng Y; Yang YP; Liu J; Li J
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of a modified scoring method for the Rush Video-Based Tic Rating Scale.
    Goetz CG; Pappert EJ; Louis ED; Raman R; Leurgans S
    Mov Disord; 1999 May; 14(3):502-6. PubMed ID: 10348478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.